 
Infection with herpes simplex virus (HSV) in the genital tract and elsewhere stimulates the production of antibody that is detectable in serum.' Secretory antibodies (S-IgA) produced in mucous membranes have been shown to have an active role in the resistance of hosts to viral and bacterial infections. 23 The presence ofmucins in cervical secretions, as well as a lack of tools to detect locally produced antibodies, have hindered the exploration of this secretory immune system. This investigation aimed to combine recently developed methods to recover proteins from cervical secretions4 with methods for detecting minute amounts of HSV type specific antibodies`7 to assess whether antibodies are produced locally in the cervical secretions of women with genital infections.
Patients, materials, and methods
We studied 49 women (median age 22, range Address for reprints: Dr Elisabeth Persson, Department of Obstetrics and Gynaecology, Karolinska Hospital, S-104 01 Stockholm, Sweden Accepted for publication 13 July 1988 years) who attended a gynaecological clinic with complaints of vaginal discharge. We took careful histories of sexually transmitted diseases (STD) (gonorrhoea, condylomata, trichomoniasis, or infection with chlamydiae or herpes) from the women, and asked whether their sexual partners had any symptoms.
Each patient then underwent pelvic examination. A sample for wet smear analysis was taken from the posterior fornix. All available cervical secretions were then sucked, under visual control, from the cervical canal with a plastic catheter (baby feeding tube, Bardic) attached to a syringe. Material from the cervix and urethra was cultured for Chlamydia trachomatis and from the cervix, urethra, and rectum for Neisseria gonorrhoeae. Cervical material from one patient was cultured for herpes simplex virus. We took 10 ml of blood from all patients for serological analyses.
Thirteen patients returned for a check after one month. The same procedure was performed on that occasion. All clinical sampling was done by one person (EP).
METHODS
We months for two years. None of these three women had symptoms or signs of current genital herpes infection at examination. Table 1 shows that 23 women had a clinical diagnosis of acute cervicitis, 11 of candidal vulvovaginitis, 10 bacterial vaginosis, and five were healthy. Culture results showed that 22 women had chlamydial infection, of whom 12 also had a clinical diagnosis of cervicitis. No gonococci were isolated. HSV 2 was isolated from the cervix of one patient. Altogether 39 women had histories of, or current, STD (including cervicitis); the other 10 had neither histories of nor current STD. Table 2 shows the titres of S-IgA against HSV type common and HSV 2 antigen in cervical secretions. Of 16 women in whom HSV 2 antibodies were detectable at a titre of 1/50 or more, 12 also reacted with the HSV type common antigen.
Of the 49 patients, 35 (71 %) had HSV type common IgG antibodies and 15 (31%) had HSV 2 IgG. All women in the latter group also had HSV type common IgG. Table 3 shows the relations between antibodies against the respective type of HSV antigen in serum and secretions. In women with antibody against HSV type common antigen the only pattern found was that high titres ofS-IgA (1/100) related to high titres ofIgG in serum. No such correlation was found in women with antibodies specific to HSV 2; in fact all five women with S-IgA at a titre of 1/100 or more had low titres (less than 1/200) of IgG in their serum. (table 2) . These samples were from six patients, all ofwhom had a clinical diagnosis of cervicitis, and three of whom yielded C trachomatis from their cervices. One of the six patients (case 1) had a history of genital herpes.
All three patients (cases 1, 2, and 3) with clinical histories of genital herpes infection had high titres of IgG against HSV type common antigen. Two (cases 2 and 3) also had high titres of serum antibodies against HSV 2, whereas one (case 1) had a negative result. Titres of S-IgA against HSV type common antigen were low in secretions from all three, whereas one (case 1) had a high titre (1/400) against HSV 2. She had chlamydial cervicitis, the other two had candidiasis.
The 12 patients with chlamydial cervicitis had a check up examination after one month, as did the patient (case 4) with HSV 2 cervicitis. All chlamydia positive patients had been treated with tetracyclines for 10 Another three patients showed significant changes (table 3) shows that patients with high titres of S-IgA were found to have low titres or not even detectable levels of IgG and vice versa. This indicates the possibility of a local immune response in the genital tract without detectable stimulation of the humoral antibody system. The high titres of serum IgG against HSV type common antigen in women without detectable S-IgA can be explained by the fact that extragenital HSV 1 infections are common. '4 When women with different clinical diagnoses were compared for the presence of S-IgA against HSV, SIgA was detected in more women with acute cervicitis than with other diagnoses (table 4). Cervical secretion is stimulated in patients with acute cervicitis as part of the defence reactions. The higher incidence of antibodies to HSV in secretions from these women could be explained by a general increase in local antibody production and by immunity triggered by previous contacts with HSV. This theory is supported by the stable concentrations of serum antibodies in samples taken from women after their cervicitis had been cured and by the stability of or decrease in S-IgA titres in most women at follow up.
In this study no routine cultures for HSV were undertaken. Current herpes infection of the cervix was therefore not excluded. Other workers have, however, found an inverse relation between S-IgA against HSV 2 and the isolation of the virus. 2 This accords with our findings in one patient (case 4) who was diagnosed as having a primary HSV 2 infection. She had IgG against HSV 2 at a titre of 1/400 in the acute phase, whereas titres of S-IgA were low (1/50). At follow up her serum concentrations had fallen and her S-IgA titres remained low.
High concentrations of S-IgA may be expected early in patients with recurrent HSV cervicitis. Recurrences of HSV 2 infection could explain the high concentrations of S-IgA against HSV 2 in case 1 in the acute phase and in case 5 at follow up. Serum antibodies were detected at follow up of case 1, which indicated a slower reactivity of the humoral antibody response.
More than half the women with cervicitis had chlamydial infection. No relation was found between the absence or presence of C trachomatis and the detection of local antibodies to HSV, which showed that there was no cross reactivity between the organisms.
No correlation was found between S-IgA and past or present STD. More women with genitally produced antibodies might be expected to give histories of HSV
